Validation of spirometry prediction equations in western Kenya
OBJECTIVE: To test the performance of three commonly used spirometry prediction equations in a healthy Kenyan population.
DESIGN: Cross-sectional assessment of healthy adults in Eldoret.
RESULTS: Of the 331 subjects enrolled in the study, 282 subjects aged 18–85 years (45% males, 55% females) produced high-quality spirograms. Lung function predictions were made using the Global Lung Initiative 2012 (GLI 2012) prediction equations for African Americans, the National Health and Nutrition Examination Survey III (NHANES III) prediction equations for African Americans, and the Crapo prediction equation. Bland-Altman analyses were performed to measure the agreement between observed and predicted spirometry parameters. Overall, the GLI 2012 and NHANES equations for African Americans performed similarly for forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1), significantly overestimating FVC while accurately predicting observed FEV1 values.
CONCLUSION: The study brings into question the utility of three major spirometry prediction equations in a Kenyan population. The significant overestimation of FVC by the best-performing equations despite accurate prediction of FEV1 suggests poor performance of these equations in our population.
Document Type: Research Article
Affiliations: 1: Division of Pulmonary, Allergy, and Critical Care Medicine, Duke Global Health Institute, Duke University, Durham, North Carolina, USA, Academic Model Providing Access to Healthcare (AMPATH), Eldoret 2: Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Department of Medicine, Moi University College of Health Sciences, Eldoret, Kenya 3: Division of Pulmonary, Allergy, and Critical Care Medicine 4: Duke Global Health Institute, Duke University, Durham, North Carolina, USA 5: Division of Pulmonary, Allergy, and Critical Care Medicine, Academic Model Providing Access to Healthcare (AMPATH), Eldoret
Publication date: January 1, 2018
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content